Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shore

Showing results (41-50 of 587) with videos related to

Pageof 59
Sort By:
Therapeutic Advances in Urology|February 2, 2013
Experience with degarelix in the treatment of prostate cancerNeal D Shore
Reviews in Urology|June 2, 2015
Thriving in the Independent Setting: Highlights From the 2014 LUGPA Annual MeetingNeal D Shore
Reviews in Urology|May 20, 2017
LUGPA Enhances 2017 Membership OpportunitiesNeal D Shore
Expert Opinion on Pharmacotherapy|May 12, 2017
Darolutamide (ODM-201) for the treatment of prostate cancerNeal D Shore
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual MeetingNeal D Shore
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1991
Separation of transcriptional activation and silencing functions of the RAP1-encoded repressor/activator protein 1: isolation of viable mutants affecting both silencing and telomere lengthL Sussel, D Shore
Health Services Research|October 21, 2014
Income dynamics and the Affordable Care ActLara D Shore-Sheppard
Cell|December 4, 1987
Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elementsD Shore, K Nasmyth
Science (New York, N.Y.)|September 4, 1987
Transcriptional regulation in the yeast life cycleK Nasmyth, D Shore
Genes & Development|March 15, 1997
A novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiaeD Wotton, D Shore
Pageof 59

Showing results (41-50 of 587) with videos related to

Sort By:
Pageof 59
Therapeutic Advances in Urology|February 2, 2013
Experience with degarelix in the treatment of prostate cancerNeal D Shore
Reviews in Urology|June 2, 2015
Thriving in the Independent Setting: Highlights From the 2014 LUGPA Annual MeetingNeal D Shore
Reviews in Urology|May 20, 2017
LUGPA Enhances 2017 Membership OpportunitiesNeal D Shore
Expert Opinion on Pharmacotherapy|May 12, 2017
Darolutamide (ODM-201) for the treatment of prostate cancerNeal D Shore
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual MeetingNeal D Shore
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1991
Separation of transcriptional activation and silencing functions of the RAP1-encoded repressor/activator protein 1: isolation of viable mutants affecting both silencing and telomere lengthL Sussel, D Shore
Health Services Research|October 21, 2014
Income dynamics and the Affordable Care ActLara D Shore-Sheppard
Cell|December 4, 1987
Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elementsD Shore, K Nasmyth
Science (New York, N.Y.)|September 4, 1987
Transcriptional regulation in the yeast life cycleK Nasmyth, D Shore
Genes & Development|March 15, 1997
A novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiaeD Wotton, D Shore
Pageof 59